Holen Sie sich die Stockscreener-App
4.845
0.31%
0.015
Handel nachbörslich:
4.84
-0.005
-0.10%
Schlusskurs vom Vortag:
$4.83
Offen:
$4.75
24-Stunden-Volumen:
984.56K
Relative Volume:
1.16
Marktkapitalisierung:
$359.80M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-28.23
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
+39.63%
1M Leistung:
+39.22%
6M Leistung:
+136.34%
1J Leistung:
-60.58%
1-Tages-Spanne:
$4.66
$4.98
1-Wochen-Bereich:
$3.49
$5.3881
52-Wochen-Spanne:
$1.60
$13.19
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
4.845 | 360.92M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Eingeleitet | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Is Perspective Therapeutics Inc. stock a smart buy before Fed meetingOptions Play & AI Powered Market Entry Strategies - newser.com
How Perspective Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trend Recap & Capital Efficiency Focused Ideas - newser.com
Will Perspective Therapeutics Inc. stock go up soonQuarterly Trade Summary & Verified Entry Point Signals - newser.com
Custom watchlist performance reports with Perspective Therapeutics Inc.Weekly Earnings Recap & Safe Entry Point Identification - newser.com
How to build a custom watchlist for Perspective Therapeutics Inc.July 2025 Momentum & Daily Chart Pattern Signals - newser.com
Applying Wyckoff theory to Perspective Therapeutics Inc. stockPrice Action & Weekly Market Pulse Alerts - newser.com
What margin trends mean for Perspective Therapeutics Inc. stock2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
BTIG Reiterates Perspective Therapeutics (CATX) Buy Recommendation - Nasdaq
Perspective Therapeutics Inc. stock momentum explainedMarket Performance Summary & Fast Exit and Entry Strategy Plans - newser.com
Perspective Therapeutics (CATX): BTIG Reiterates 'Buy' Rating wi - GuruFocus
Can Perspective Therapeutics Inc. recover in the next quarter2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Will Perspective Therapeutics Inc. see short term momentumJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Candlestick signals on Perspective Therapeutics Inc. stock todayJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - newser.com
Can Perspective Therapeutics Inc. (AAJ0) stock sustain free cash flowJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Using Bollinger Bands to evaluate Perspective Therapeutics Inc.Oil Prices & Consistent Growth Equity Picks - newser.com
Can Perspective Therapeutics Inc. rally from current levelsJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Has Perspective Therapeutics Inc. found a price floor2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
BTIG initiates coverage on Perspective Therapeutics stock with Buy rating By Investing.com - Investing.com Nigeria
BTIG Initiates Coverage of Perspective Therapeutics (CATX) with Buy Recommendation - Nasdaq
BTIG initiates coverage on Perspective Therapeutics stock with Buy rating - Investing.com
BTIG Research Initiates Coverage on Perspective Therapeutics With Buy Rating, $14 Price Target - MarketScreener
BTIG Initiates Coverage on CATX with a Buy Rating and $14 Target - GuruFocus
Technical analysis overview for Perspective Therapeutics Inc. stock - newser.com
Will Perspective Therapeutics Inc. stock outperform small cap peers2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
Real time social sentiment graph for Perspective Therapeutics Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
How robust is Perspective Therapeutics Inc. stock financial positionJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Why Perspective Therapeutics Inc. (AAJ0) stock stays undervaluedTrade Signal Summary & Long-Term Safe Investment Plans - newser.com
How dovish Fed policy supports Perspective Therapeutics Inc. (AAJ0) stock2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Will Perspective Therapeutics Inc. rebound enough to break evenWeekly Gains Summary & High Conviction Trade Alerts - newser.com
Volatility clustering patterns for Perspective Therapeutics Inc.Portfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
Top chart patterns to watch in Perspective Therapeutics Inc.2025 Market Trends & Verified Entry Point Signals - newser.com
Perspective Therapeutics Inc. stock outlook for YEARMarket Trend Summary & Daily Technical Forecast Reports - newser.com
Can Perspective Therapeutics Inc. stock reach $200 price target2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Analyzing Perspective Therapeutics Inc. with risk reward ratio charts2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Applying Elliott Wave Theory to Perspective Therapeutics Inc.Gap Up & Free Fast Entry Momentum Trade Alerts - newser.com
What drives Perspective Therapeutics Inc AAJ0 stock priceMoving Average Crossovers & Free Record-Breaking Gains - earlytimes.in
Perspective Therapeutics, Inc. Common Stock (NYSE:CATX) Stock Quote - FinancialContent
How Perspective Therapeutics Inc. (AAJ0) stock valuation compares with sectorMarket Activity Report & Safe Entry Momentum Tips - newser.com
Heatmap analysis for Perspective Therapeutics Inc. and competitorsTrend Reversal & Safe Entry Momentum Tips - newser.com
Is Perspective Therapeutics Inc. (AAJ0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - newser.com
Is Perspective Therapeutics Inc. stock attractive for retirement portfoliosWeekly Stock Recap & Consistent Growth Equity Picks - newser.com
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Perspective Therapeutics Inc-Aktie (CATX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Spoor Johan M. | Chief Executive Officer |
Mar 28 '25 |
Buy |
2.21 |
4,650 |
10,288 |
4,650 |
| Williamson Robert F III | Director |
Mar 31 '25 |
Buy |
2.14 |
38,145 |
81,775 |
108,982 |
| Williamson Robert F III | Director |
Mar 28 '25 |
Buy |
2.27 |
22,192 |
50,376 |
70,837 |
| Graham Juan | Chief Financial Officer |
Mar 28 '25 |
Buy |
2.25 |
33,333 |
74,946 |
35,354 |
| Woods Lori A | Director |
Mar 31 '25 |
Buy |
2.13 |
23,475 |
49,999 |
183,460 |
| HENSON HEIDI | Director |
Dec 04 '24 |
Buy |
3.85 |
25,975 |
100,004 |
25,975 |
| Spoor Johan M. | CEO |
Dec 04 '24 |
Buy |
3.77 |
8,000 |
30,132 |
36,257 |
| Williamson Robert F III | Director |
Nov 25 '24 |
Buy |
3.64 |
6,266 |
22,814 |
430,058 |
| Hunt Jonathan Robert | Chief Financial Officer |
Nov 25 '24 |
Buy |
3.82 |
12,829 |
48,974 |
48,800 |
| Spoor Johan M. | CEO |
Nov 25 '24 |
Buy |
3.78 |
14,500 |
54,868 |
152,072 |
1.22%
1.22%
Kapitalisierung:
|
Volumen (24h):